-
Checkpoint Therapeutics CEO On Tapping Into A $25 Billion Cancer Treatment Market
Wednesday, May 20, 2020 - 8:33am | 1382The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Since its establishment in 2014 by founding company Fortress Biotech, Inc. (NASDAQ: FBIO), biopharmaceutical company Checkpoint...